Heart Failure

Universal Academy.

Blog | News

Heart Failure Universal Academy | 1ST Edition

Milano Novotel Ca’ Granda | 8/9 Maggio 2025

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ QoL (Quality of Life) in HeartFailure.

The heart of the matter. A scientific statement of the hashtag#HFA and the hashtag#EAPC of the European Society of Cardiology

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ EMPULSE subanalysis

πŸ€ Another proof of safety & efficacy of SGLT2i in AHF with Low BP πŸ’‘ A further confirmation of the Smart effect on Blood Pressure

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ IRONMAN trial : 1st study that show no risk of infection after IV ferrum in HFrEF

βœ… No death☠️ of hospitalizations πŸ₯ due to infection after iron

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ VICTOR trial : baseline characteristics of enrolled populations compared to other RCTs in HFrEF

βœ… Will be Vericiguat the 5th pillar in HFrEF? 🎯 The aim is to complete the spectrum partially covered by VICTORIA beyond WorseningHF in HFrEF

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Silencers vs stabilizers in TTR amyloid cardiomyopathy

Are we asking the wrong questions? πŸ”¬ Not a great difference between the 2 classes In several cases the disease keeps progressing 🧨 βœ… Waiting for amyloid removers πŸ” Long & winding road to the understanding of amyloidosis pathophysiology πŸ€” Fibrosis & collagen production significant part of the process ❓ Why someone develops wild-type ATTR ( or SSA) & others...

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Beta_blockers in HFmrEF & HFpEF >16000 pts

βœ… Association with ⬇️ CV ☠️ & HHF πŸ₯ in both groups ✳️ Be careful to chronotropic incompetence

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ πŸ—žοΈ CANVAS & CREDENCE pooled analysis

Another proof of diuretic effect of SGLT2i

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ FIDELITY subanalysis: Finerenone efficacy & Safety in CKD & T2DM, by diuretic use ~ 13.000 pts

No difference with or without diuretics about: Cardiovascular Death ☠️ + HF hospitalization πŸ₯Kidney outcomes πŸ‘‚πŸ»

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ SUGAR_DM_HF: CardiovascularMagneticResonance estimated Pulmonary CapillaryWedge Pressure & congestion markers, & effect of empagliflozin in HFrEF in pre_diabets & T2DM

⚑️ A new tool of CMR that can provide another evolution for multimodality imaging in HeartFailure

read and comment the article

Blog | European Journal of Heart Failure

HappyNewYear Linkedin CardioVascularCommunity by the HeartFailureUniversalAcademy. HFUA

Let’s start 2025 with a hot HeartFailure topic πŸ”₯ Prediction of HF Events in DCM & HFmrEF using multiparametric CMR

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Machine learning approach to identify phenotypes in patients with ischaemic HFrEF

HFUA HeartFailureUniversalAcademy It will be the future of phenotyping?

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯Outpatient WorseningHF & mortality in transthyretin cardiomyopathy

πŸ‘‰Oral diuretic intensification (ODI) predicts mortality ☠️ as HeartFailure Hospitalizations πŸ₯ πŸ‘‰ This in ATTR_CMP on treatment with tafamidis

read and comment the article

Blog | European Journal of Internal Medicine

πŸ”₯ Our observational study based on data of Regione Lombardia on more than 10 millions people showed a significant association between HeartFailure & Non_Cardiac_Comorbidites

A mean of 42 months of follow-up (2015-2019) βœ… More comorbidities associated with All_cause_death☠️ and ⬆️ rate of re-hospitalizations πŸ₯ βœ… The higher the n^ of comorbidities the longer the length of hospitalization 🚹🚺 Same data for both sexes ❗️ HF pts with 4 or more non cardiac comorbidities had a mean length of hospitalization of 45 days

read and comment the article

Blog | Roche

Il cuore Γ¨ un organo endocrino che produce i peptidi natriuretici in risposta allo stress di parete che si genera nello scompenso cardiaco.

Il cuore Γ¨ un organo endocrino che produce i peptidi natriuretici in risposta allo stress di parete che si genera nello scompenso cardiaco. L’ormone principale con effetti sistemici Γ¨ il BNP, che viene prodotto come pro-ormone e poi scisso porzione attiva BNP e in quella non attiva NTproBNP. Il sistema dei peptidinatriuretici Γ¨ il principale sistema neuro-ormonale che antagonizza gli...

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯DREAM_HF : Mesenchymal precursor cells ⬇️ ☠️ & major morbidity in ischemic HeartFailure with inflammation

πŸ€ A new hope beyond traditional pharmacological & devices therapy

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Gene 🧬 therapy in HeartFailure : HFA , European Society of Cardiology Council on CV genomics & WG Myocardial & Pericardial Diseases Scientific Statement

⚑️ State of art and future perspectivesπŸ“• Amyloidosis new therapiesπŸ“˜πŸ“™πŸ“— Dilated, Hypertrophic,Restrictive and Arrhythmogenic CardiomyopathiesπŸ§€ Hypercolesterolemia

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Water & Salt Balance in HF

πŸ‘‰ Not only sodium & salt πŸ§‚ , but the majority is water πŸ’§

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Cardiovascular toxicities of immunotherapy for cancer πŸ’‰ ☠️

πŸ‘‰ Incidence, Pathophysiology & Management of AdverseEvent by HFA & CardioOncology Council European Society of Cardiology

read and comment the article

Blog | Roche

Lo Scompenso Cardiaco colpisce piΓΉ di 1 milione di persone in Italia, Γ¨ la 1Βͺ causa di ospedalizzazione al mondo ed Γ¨ gravato da un alto tasso di mortalitΓ  – piΓΉ alto di molti cancri – e di re-ospedalizzazione. ☠️ πŸ₯

I sintomi sono spesso aspecifici e in 1 un paziente su 3 portano a diagnosi errate. In generale lo Scompenso Cardiaco rimane largamente sottodiagnosticato, infatti circa l’80% dei pazienti riceve la diagnosi a seguito di un ricovero per Scompenso Cardiaco Acuto. 🚨 Questo espone i pazienti ad un rischio incrementale di morte del 28% rispetto ad un paziente che riceve...

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ VICTOR trial design : Vericiguat in Chronic HFrEF

Will be vericiguat ready to be the 5th pharmacological pillar in HFrEF ? HFUA HeartFailureUniversalAcademy

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ The 25in25 initiative : A novel project to reduce HF ☠️ 25% in the next 25 y

HFprevalence is still alarmingly raising 🚨 Detect the undetected & treat it πŸ€ HFUA

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Microvascular obstruction (MVO) in amyloidosis

MVO is associated with an ⬆️ risk of ☠️ in AL but not in ATTR βœ…This reflects the intrinsic differences between these 2 forms of CA πŸ’€ The toxic effect of light chain amyloidosis. AL . One of the cultural legacies of Prof RapezziπŸ’‘ πŸ™

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ FOREST_HCM : Aficamtem in Non-Obstructive HCM (HNOCM)

⬆️ Symptoms (NYHA) QoL (KCCQ) ⬇️ TnI & NTproBNP πŸ€ Safe with mild ⬇️ of LVEF πŸ’Š A new treatment for HNOCM is coming

read and comment the article

Blog | Minerva Cardiology Angiology

πŸ”₯ Our article dedicated to a new predictive score in extrasystolic arrhythmia : β€œEX-prognosis”

A beautiful idea of Olga Germanova Thanks to all the authors Giuseppe Biondi Zoccai Minerva Cardiology Angiology

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Diabetic myocardial disorder

A new statement of HFA & European Society of Cardiology WG on Myocardial & Pericardial Diseases A complex interplay in the CardioRenalMetabolic axis

read and comment the article

Blog | World Heart Day

World Heart Day

Cardiovascular Diseases are the 1st cause of ☠️ and HeartFailure is the 1st cause of hospitalization globally 🌍 ! Let’s fight them together ! ProtectΒ  Heart ❀️ πŸ«€ Cardiovascular Diseases produced a cost only in the European Union and only for 2021 of 282 billions of euros πŸ’Ά πŸ”₯

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Association of Multiple Non HCM & outcomes in HCM

A new study on multiple mutations & poor outcomes in HCM 🧬 See our recent editorial β€œThe Role of Multiple Mutations in HCM – A New Universe to discover πŸ”₯ Multiple mutations in HCM are associated with End_Stage or Hypokinetic & Dilated evolution & with HF & arrhythmia development

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Aetiology & Clinical manifestations of NDLVC

πŸ€ Genetic a prevalent causeπŸ”¬ Myocarditis can uncover a genetic CMPπŸ«€ NDLVC a starting disease phenotype

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ HF risk assessment in HCM based on the H2FPEF score

Risk prediction in both HOCM & HNOCM HCM a cause not a β€œmimic” of HFpEF

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ DECISION A new RCT on low dose digoxin in HF with LVEF < 50% both sinus rhythm & AF

Will be the last trial on the topic? Maybe we will obtain a final answer πŸ€

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ EXPAND: A real life study that confirms that the major driver of benefits of MitraClip in FMR & HFrEF

EXPAND a study that shows the same results of a fresh meta-analysis which included COAPT MITRA_FR & RESHAPE_HF2 > more than 800 pts With due differences among populations but for the same disease

read and comment the article

Blog | The new england journal of medicine

πŸ”₯❀️‍πŸ”₯FINEARTS_HF. FineHearts_HF

Finerenone confirmed a 16% RRR of CV ☠️ & Total HHF πŸ₯ A 2nd pillar for HFmrEF & HFpEF has just been built πŸ›οΈ The need of new #2025 HFguidelines is now urgent!

read and comment the article

Blog | The new england journal of medicine

πŸ”₯ RESHAPE_HF2 NEJM Confirmed an important role of MitraClip in FMR & HFrEF

Similar effects of ARNI & SGLT2i RESHAPE_HF unveiled the grey part of the major benefit of MITRA_Clip is HHF Intermediate characteristics between MITRA_FR & COAPT & intermediate results between the 2 trials Drug & devices similar effects in HFrEF

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Implementation of GDMT for HeartFailure : Progress achieved, work ahead !

πŸ‹οΈβ€β™€οΈ Still a lot of job to do to implement GDMT HF ☠️ still not significantly changed due to poor use of new therapies!

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ NATRIUM_HF: Congestion & ⬆️ response to fluid/Na+ challenge in HFrEF after ARNI initiation

βœ… Another proof of diuretic, natriuretic & Weight ⬇️ effect of ARNI

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Mechanisms of myocardial Reverse Remodeling: statement of European Society of Cardiology WG on myocardial function

From stressors, physiopathological models, therapeutic effects of drugs & devices & new treatments

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ πŸ—žοΈ VICTORIA echocardiography substudy:

⬇️ of biomarkers related to inflammation & cardiac metabolism (TNF_R1 & PRTN3) associated with reverse remodeling in HFrEF

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Updated Quality indicators for the care & outcomes of HeartFailure

Congrats to European Society of Cardiology hashtag#HFA Priv.-Doz. Dr. Amr Abdin for the eye-catching & instantly understable paper

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Change in 6mwt is an independent predictor of all-cause death in HFrEF

Discover the simple & easy to use 6mwt in HFrEF a predictor of ☠️ independent of: NYHA NTproBNP

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ RESHAPE_HF2 High time to discover the grey part between the white (COAPT) & black side (MITRA_FR) of the moon πŸŒ–

MitraClip in FMR & HFrEF πŸ‘‰ Intermediate characteristics between COAPT & MITRA_FR πŸ‘‰ ⬆️ % of ARNI & STLT2i use πŸ€Results soon at ESCCongress

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Updated Quality indicators for the care & outcomes of HeartFailure

Congrats to European Society of Cardiology hashtag#HFA Priv.-Doz. Dr. Amr Abdin for the eye-catching & instantly understable paper

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ FINEHEARTS_HF

πŸ”Discover the characteristics of HF population enrolled.The new kid on the block in HF & CardioRenalMetobolic area is coming soon at ESCCongress Finererone a new MRAHFUAEJHF πŸ” πŸ‘‰ 36% HFmrEFπŸ‘‰ 45% HFpEF (EF:50-60%)πŸ‘‰19% HFpEF>60%

read and comment the article

Blog | European Journal of Heart Failure

πŸ€A pleasure to collaborate again with the EJHF & European Society of Cardiology with Priv.-Doz. Dr. Amr Abdin & Han Naung Tun

Thank to Prof BΓΆhm the Editor in Chief of the hashtag#EJHF for the invitation The best is yet to come πŸ€

read and comment the article

Blog | European Journal of Heart Failure

πŸ”₯ Our new editorial on Cardiology πŸ€

β€œThe Role of Multiple Mutations in HCM – A New Universe to Discover:Proof of Guiltiness of the Genetic Burden in Worsening Hypertrophic Cardiomyopathy Natural History πŸ”¬ 🧬 Discover the role of multiple mutations & especially of calcium channels gene + sarcomeric mutations in HCM through our last editorial on Cardiology

read and comment the article